Log In
BCIQ
Print this Print this
 

JOT101

  Manage Alerts
Collapse Summary General Information
Company Jupiter Orphan Therapeutics Inc.
DescriptionFormulation of pharmaceutical grade trans-resveratrol (RSV)
Molecular Target
Mechanism of Action 
Therapeutic Modality 
Latest Stage of DevelopmentPhase I
Standard IndicationAtaxia
Indication DetailsTreat Friedreich's ataxia
Regulatory Designation
Partner

 Product Details
 Archive Items are loading loading
Collapse Summary Deals Information
 Deals Details
Get a free BioCentury trial today